ConductScience.org, home

Paper664136

Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.

Andersson L and 4 others. Urol Res, 1978. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Papers, record 664136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/664136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases.
PubMed
Journal
Urol Res
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.32
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Andersson LL
2Eriksson OO
3Hedlund POP O
4Kjellman HH
5Lindqvist BB

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Kidney DiseasesMajor topic
Tranexamic AcidMajor topic
Biological Availability
Chronic Disease
Creatinine
Glomerulonephritis
Half-Life
Hematuria
Humans
Injections, Intravenous
Kidney
Kidney Failure, Chronic
Nephrosclerosis
Pyelonephritis
Urination Disorders

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14566005The effect of tranexamic acid (AMCA) on postoperative bleeding after conization.Acta Obstet Gynecol Scand1972https://conductscience.org/library/papers/4566005PubMed
2785936Tranexamic acid (AMCA) and late hyphaema. A double blind study in cataract surgery.Acta Ophthalmol (Copenh)1976https://conductscience.org/library/papers/785936PubMed
34718188The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.Acta Neurol Scand1973https://conductscience.org/library/papers/4718188PubMed
44912802Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. A double blind study.Scand J Urol Nephrol1969https://conductscience.org/library/papers/4912802PubMed
55254275Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.Ann N Y Acad Sci1968https://conductscience.org/library/papers/5254275PubMed
65324474Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation.Acta Obstet Gynecol Scand1965https://conductscience.org/library/papers/5324474PubMed
7946728Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid.Acta Ophthalmol (Copenh)1976https://conductscience.org/library/papers/946728PubMed
84422030Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4422030PubMed
94940818Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.J Reprod Med1970https://conductscience.org/library/papers/4940818PubMed
105423063Antifibrinolytic treatment with tranexamic acid (AMCA) in pediatric urinary tract surgery.J Pediatr Surg1970https://conductscience.org/library/papers/5423063PubMed
115393836AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.Scand J Urol Nephrol1969https://conductscience.org/library/papers/5393836PubMed
125955253Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.Acta Obstet Gynecol Scand1966https://conductscience.org/library/papers/5955253PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
41958933The influence of tranexamic acid on intraoperative blood transfusion in short-segment PLIF and analysis of influencing factors of the transfusion: a retrospective case study.Front Pharmacol2026https://conductscience.org/library/papers/41958933PubMed
38830735Hospital policy of tranexamic acid to reduce transfusion in major non-cardiac surgery (TRACTION): protocol for a phase IV randomised controlled trial.BMJ Open2024https://conductscience.org/library/papers/38830735PubMed
37601774The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial.Front Med (Lausanne)2023https://conductscience.org/library/papers/37601774PubMed
37280562Effect of preoperative prophylactic intravenous tranexamic acid on perioperative blood loss control in patients undergoing cesarean delivery: a systematic review and meta-analysis.BMC Pregnancy Childbirth2023https://conductscience.org/library/papers/37280562PubMed
34838063
Application of an adjusted patient blood management protocol in patients undergoing elective total hip arthroplasty: towards a zero-percent transfusion rate in renal patients-results from an observational cohort study.
J Orthop Surg Res2021https://conductscience.org/library/papers/34838063PubMed
33341923Renal ischemic adverse drug events related to tranexamic acid in women of child-bearing age: an analysis of pharmacovigilance data.Eur J Clin Pharmacol2021https://conductscience.org/library/papers/33341923PubMed
33191708[Progress on the application of tranexamic acid in adolescent spine corrective surgery].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi2020https://conductscience.org/library/papers/33191708PubMed
32918670Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery.J Thromb Thrombolysis2021https://conductscience.org/library/papers/32918670PubMed
32899057Effect of 3 different anticoagulants on hidden blood loss during total hip arthroplasty after tranexamic acid.Medicine (Baltimore)2020https://conductscience.org/library/papers/32899057PubMed
32144522Tranexamic acid attenuates inflammatory effect and modulates immune response in primary total knee arthroplasty: a randomized, placebo-controlled, pilot trial.Inflammopharmacology2020https://conductscience.org/library/papers/32144522PubMed
29879947The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial.BMC Pregnancy Childbirth2018https://conductscience.org/library/papers/29879947PubMed
29505518Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study.Medicine (Baltimore)2018https://conductscience.org/library/papers/29505518PubMed
28439166End Stage Renal Disease: Not a Contraindication for Minor Oral Surgery-Protocol for the Management of Oral Surgery patients with ESRD on Hemodialysis.J Maxillofac Oral Surg2017https://conductscience.org/library/papers/28439166PubMed
26349843Randomized clinical trial of topical tranexamic acid after reduction mammoplasty.Br J Surg2015https://conductscience.org/library/papers/26349843PubMed
21716688Tranexamic Acid treatment of life-threatening hematuria in polycystic kidney disease.Int J Nephrol2011https://conductscience.org/library/papers/21716688PubMed
12825966Tranexamic acid: a review of its use in the management of menorrhagia.Drugs2003https://conductscience.org/library/papers/12825966PubMed
7282453Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.Acta Neurochir (Wien)1981https://conductscience.org/library/papers/7282453PubMed
7000850Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/7000850PubMed
7000846Clinical pharmacology of aminocaproic and tranexamic acids.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/7000846PubMed
2580684Clinical application of inhibitors of fibrinolysis.Drugs1985https://conductscience.org/library/papers/2580684PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/664136

GET https://conductscience.org/api/papers/v1/664136/authors